First-in-human data for novel platelet glycoprotein IIb/IIIa inhibitor RUC-4 in patients with STEMI Nov. 18, 2019
Sparsentan does not appear to have a negative effect on quality of life in FSGS patients Nov. 18, 2019
RSS